Using a Cell Line Breast Cancer Progression System to Identify Biomarker Candidates
Overview
Affiliations
Biological Significance: Identifying glycoproteins differentially expressed during cancer progression results in information on the biological processes and key pathways associated with cancer. In addition, new hypotheses and potential biomarkers result from these glycoproteomic studies. Our glycoproteomic analysis of this model of breast cancer provides a roadmap for future experimental interventions to further tease apart critical components of tumor progression.
Impact of radiofrequency ablation (RFA) on bone quality in a murine model of bone metastases.
Ghomashchi S, Whyne C, Chinnery T, Habach F, Akens M PLoS One. 2021; 16(9):e0256076.
PMID: 34495961 PMC: 8425524. DOI: 10.1371/journal.pone.0256076.
Suttapitugsakul S, Tong M, Sun F, Wu R Anal Chem. 2021; 93(4):2694-2705.
PMID: 33397101 PMC: 8034805. DOI: 10.1021/acs.analchem.0c05126.
Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis.
Martins Cavaco A, Damaso S, Casimiro S, Costa L Cancer Metastasis Rev. 2020; 39(3):603-623.
PMID: 32447477 DOI: 10.1007/s10555-020-09888-5.
Glycoproteins in Claudin-Low Breast Cancer Cell Lines Have a Unique Expression Profile.
Yen T, Bowen S, Yen R, Piryatinska A, Macher B, Timpe L J Proteome Res. 2017; 16(4):1391-1400.
PMID: 28287265 PMC: 5557415. DOI: 10.1021/acs.jproteome.6b00470.
Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.
Goddard E, Hill R, Barrett A, Betts C, Guo Q, Maller O Int J Biochem Cell Biol. 2016; 81(Pt A):223-232.
PMID: 27771439 PMC: 5459605. DOI: 10.1016/j.biocel.2016.10.014.